Demographics, histology, and autoantibody-associated phenomena for 17 patients with thymic neoplasm
Patient . | Age at diagnosis/sex . | Age at study enrollment . | WHO classification . | Opportunistic infections . | Other paraneoplastic conditions . | No. of anti-cytokine autoantibodies . |
---|---|---|---|---|---|---|
1 | 34/M | 40 | B2 | CMC, dVZV | 8 | |
2 | 58/F | 61 | B2 | CMC, S apiospermum, and M avium sinopulmonary disease | 11 | |
3 | 18/F | 23 | B2 | Myasthenia gravis, type 1 diabetes mellitus with anti–GAD-65 autoantibodies | 2 | |
4 | 44/F | 53 | Thymoma* | Myasthenia gravis; eosinophilic fasciitis | 2 | |
5 | 45/M | 48 | B2/B3 | CMC | Myasthenia gravis | 5 |
6 | 51/M | 57 | B3 | 0 | ||
7 | 48/F | 50 | B1 | 6 | ||
8 | 67/F | 71 | C | 6 | ||
9 | 36/M | 45 | B3 | Disseminated cryptococcosis (lung, blood, liver) | Coombs positive hemolytic anemia; Sweet syndrome | 6 |
10 | 34/F | 35 | B3 | Myasthenia gravis | 0 | |
11 | 36/M | 42 | B2/B3 | 8 | ||
12 | 53/F | 53 | C | 0 | ||
13 | 41/F | 41 | B2 | 6 | ||
14 | 27/M | 31 | C | Cushing syndrome | 0 | |
15 | 39/M | 39 | C | 0 | ||
16 | 55/F | 57 | B3 | 1 | ||
17 | 59/M | 66 | B3 | dVZV | 3 |
Patient . | Age at diagnosis/sex . | Age at study enrollment . | WHO classification . | Opportunistic infections . | Other paraneoplastic conditions . | No. of anti-cytokine autoantibodies . |
---|---|---|---|---|---|---|
1 | 34/M | 40 | B2 | CMC, dVZV | 8 | |
2 | 58/F | 61 | B2 | CMC, S apiospermum, and M avium sinopulmonary disease | 11 | |
3 | 18/F | 23 | B2 | Myasthenia gravis, type 1 diabetes mellitus with anti–GAD-65 autoantibodies | 2 | |
4 | 44/F | 53 | Thymoma* | Myasthenia gravis; eosinophilic fasciitis | 2 | |
5 | 45/M | 48 | B2/B3 | CMC | Myasthenia gravis | 5 |
6 | 51/M | 57 | B3 | 0 | ||
7 | 48/F | 50 | B1 | 6 | ||
8 | 67/F | 71 | C | 6 | ||
9 | 36/M | 45 | B3 | Disseminated cryptococcosis (lung, blood, liver) | Coombs positive hemolytic anemia; Sweet syndrome | 6 |
10 | 34/F | 35 | B3 | Myasthenia gravis | 0 | |
11 | 36/M | 42 | B2/B3 | 8 | ||
12 | 53/F | 53 | C | 0 | ||
13 | 41/F | 41 | B2 | 6 | ||
14 | 27/M | 31 | C | Cushing syndrome | 0 | |
15 | 39/M | 39 | C | 0 | ||
16 | 55/F | 57 | B3 | 1 | ||
17 | 59/M | 66 | B3 | dVZV | 3 |
CMC indicates chronic mucocutaneous candidiasis; and dVZV, disseminated varicella zoster virus
World Health Organization (WHO) classification not available.